MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.rmed.2026.108655

Медицинская библиотека · Respiratory medicine · 2026

Prognosis of patients with bronchiectasis receiving long-term oxygen therapy.

Ono Kazuki, Ito Masashi, Harada Risako, Ohe Takashi, Furuuchi Koji, Fujiwara Keiji, Kodama Tatsuya, Tabusadani Mitsuru, Morimoto Kozo

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

Long-term oxygen therapy (LTOT) for bronchiectasis is recommended using the same eligibility criteria as for chronic obstructive pulmonary disease (COPD); however, the evidence supporting LTOT in bronchiectasis is limited, and no studies have evaluated the prognosis of the disease in these patients. The aim of the present study was to investigate the characteristics and prognosis of bronchiectasis in patients receiving LTOT.

METHODS

This retrospective cohort study included patients with bronchiectasis and COPD who started LTOT between April 2011 and September 2022. Patients with interstitial lung disease (ILD) who started LTOT after June 2020 while receiving antifibrotic therapy were also included. We compared baseline characteristics and survival times among patients with bronchiectasis, COPD, and ILD. Furthermore, among patients with bronchiectasis, we compared these parameters between those with nontuberculous mycobacteria (NTM) culture-positive and NTM culture-negative results.

RESULTS

A total of 93 consecutive patients with bronchiectasis were newly initiated on LTOT. Compared with patients with COPD and ILD, those with bronchiectasis had a significantly lower BMI, %FVC and %FEV. Survival was significantly shorter in patients with bronchiectasis (664 [372-1078] days) than in those with COPD (1008 [590-1722] days), whereas no significant difference was observed compared to ILD (669 [208-989] days). Patients who were NTM culture-positive (405 [156-646] days) had a significantly shorter survival than those who were NTM culture-negative (946 [573-1380] days).

CONCLUSIONS

The prognosis of bronchiectasis in patients was extremely poor, worse than that of COPD and comparable to that of ILD.

Для цитирования: Ono Kazuki, Ito Masashi, Harada Risako, Ohe Takashi, Furuuchi Koji, Fujiwara Keiji, Kodama Tatsuya, Tabusadani Mitsuru, Morimoto Kozo. Prognosis of patients with bronchiectasis receiving long-term oxygen therapy.. Respiratory medicine. 2026. DOI: 10.1016/j.rmed.2026.108655.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.